| 000 | 01737 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514015525.0 | ||
| 264 | 0 | _c20011228 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0017-5749 | ||
| 024 | 7 |
_a10.1136/gut.49.6.783 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKruis, W | |
| 245 | 0 | 0 |
_aLow dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. _h[electronic resource] |
| 260 |
_bGut _cDec 2001 |
||
| 300 |
_a783-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAminosalicylic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aColon _xpathology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesalamine _xadministration & dosage |
| 650 | 0 | 4 | _aPhenylhydrazines |
| 650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
| 700 | 1 | _aSchreiber, S | |
| 700 | 1 | _aTheuer, D | |
| 700 | 1 | _aBrandes, J W | |
| 700 | 1 | _aSchütz, E | |
| 700 | 1 | _aHowaldt, S | |
| 700 | 1 | _aKrakamp, B | |
| 700 | 1 | _aHämling, J | |
| 700 | 1 | _aMönnikes, H | |
| 700 | 1 | _aKoop, I | |
| 700 | 1 | _aStolte, M | |
| 700 | 1 | _aPallant, D | |
| 700 | 1 | _aEwald, U | |
| 773 | 0 |
_tGut _gvol. 49 _gno. 6 _gp. 783-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.49.6.783 _zAvailable from publisher's website |
| 999 |
_c11624331 _d11624331 |
||